[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![MoonLake Immunotherapeutics Class A Ordinary Shares Graphic](https://lunarcrush.com/gi/w:26/t:$mltx.png) MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

MoonLake Immunotherapeutics (MLTX) is seeing positive momentum with analyst upgrades and potential acquisition interest. Influential creators are engaging with the stock, driving positive sentiment and market activity.

### About MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is a stock in the healthcare sector.  
MoonLake Immunotherapeutics Class A Ordinary Shares uses the ticker $MLTX for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$mltx/insights)
- MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) posts created is up XXXXXX% from the previous X months.

### Price: $XXXXX [#](/topic/$mltx/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:close.svg)  
[Price 24-Hour Chart Data](/topic/$mltx/time-series/close.tsv)  
The current price increase of XXXX% in the last XX hours is likely driven by positive analyst upgrades, the potential acquisition interest, and recent engagement from influential creators in the social space, which are all contributing to positive sentiment and market activity.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| -XXXX%  | XXXX% | XXXXX% |

**1-Year High**: $XXXXX on 2024-12-17  
**1-Year Low**: $XXXXX on 2025-04-08  
  
  
### AltRank: XXXXX [#](/topic/$mltx/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:alt_rank.svg)  
[AltRank 24-Hour Chart Data](/topic/$mltx/time-series/alt_rank.tsv)  
MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) is currently AltRank #1,308 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXXXX +1,406  
**1 Month**: XXXXX +703  
**6 Months**: XXXXX +1,127  
**1 Year**: XXXXX +1,326  
**1-Year High**: XXXXX on 2025-03-08  
**1-Year Low**: XX on 2025-06-03  
  
  
### Galaxy Score: XXXXX [#](/topic/$mltx/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:galaxy_score.svg)  
[Galaxy Score 24-Hour Chart Data](/topic/$mltx/time-series/galaxy_score.tsv)  
**Current Value**: XXXXX  
**Daily Average**: XX  
**1 Week**: XX -XX  
**1 Month**: XX -X  
**6 Months**: XX -XX  
**1 Year**: XX +13  
**1-Year High**: XX on 2024-10-16  
**1-Year Low**: XX on 2024-09-02  
  
  
### Engagements: XXXXXX [#](/topic/$mltx/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:interactions.svg)  
[Engagements 24-Hour Chart Data](/topic/$mltx/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXX  
**1 Week**: XXXXXXX -XXXX%  
**1 Month**: XXXXXXX -XX%  
**6 Months**: XXXXXXXXX +72%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-06-03  
**1-Year Low**: XXX on 2024-12-29  

| Social Network | X      |
| -------------- | -      |
| Engagements    | XXXXXX |
  

  
  
### Mentions: XX [#](/topic/$mltx/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:posts_active.svg)  
[Mentions 24-Hour Chart Data](/topic/$mltx/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XXX -XX%  
**1 Month**: XXX +134%  
**6 Months**: XXXXX +33%  
**1 Year**: XXXXX +53%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2024-10-03  

| Social Network | X  |
| -------------- | -  |
| Mentions       | XX |
  

  
  
### Creators: XX [#](/topic/$mltx/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:contributors_active.svg)  
[Creators 24-Hour Chart Data](/topic/$mltx/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Week**: XX -XX%  
**1 Month**: XXX +261%  
**6 Months**: XXXXX +97%  
**1 Year**: XXXXX +228%  
**1-Year High**: XXX on 2025-06-27  
**1-Year Low**: X on 2024-07-31  

The most influential creators that mention MoonLake Immunotherapeutics Class A Ordinary Shares in the last XX hours

| Creator                                    | Rank | Followers | Posts | Engagements |
| -------                                    | ---- | --------- | ----- | ----------- |
| [@BiopharmIQ](/creator/twitter/BiopharmIQ) | X    | XXXXXX    | X     | XXXXXX      |
| [@Andre_AGTC](/creator/twitter/Andre_AGTC) | X    | XXXXX     | X     | XXX         |

[View More](/list/creators/$mltx/100)
  
  
### Sentiment: XX% [#](/topic/$mltx/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:sentiment.svg)  
[Sentiment 24-Hour Chart Data](/topic/$mltx/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% no change  
**1 Month**: XX% +13%  
**6 Months**: XX% +14%  
**1 Year**: XX% +76%  
**1-Year High**: XXX% on 2024-07-31  
**1-Year Low**: XX% on 2024-12-09  

**Most Supportive Themes**
- **Analyst Upgrades:** (65%) Numerous analysts have upgraded MLTX, suggesting a positive outlook on the stock's potential.
- **Investment Potential:** (20%) Posts highlight potential investment opportunities and high impact catalysts, suggesting confidence in future growth.
  
**Most Critical Themes**
- **Declining Social Engagement:** (15%)  A recent decline in social engagement metrics has been observed over the past month.
  
Network engagement breakdown:  
| Network | Positive | %  | Neutral | %   | Negative | %  |
| ------- | -------- | -  | ------- | -   | -------- | -  |
| X       | XXX      | X% | XXXXXX  | XX% | X        | X% |
|         |          |    |         |     |          |    |
| Total   | XXX      | X% | XXXXXX  | XX% | X        | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$mltx/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:social_dominance.svg)  
[Social Dominance 24-Hour Chart Data](/topic/$mltx/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXXXX% -XXXXXXX%  
**1 Month**: XXXXX% -XXXXX%  
**6 Months**: XXXXX% -XXXXXX%  
**1 Year**: XXXXX% +0.0048%  
**1-Year High**: XXXXX% on 2025-06-04  
**1-Year Low**: XXXXXX% on 2024-07-31  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$mltx/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:market_dominance.svg)  
[Market Dominance 24-Hour Chart Data](/topic/$mltx/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2024-10-04  
**1-Year Low**: XXXXXXX% on 2025-03-11  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$mltx/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mltx/c:line/m:market_cap.svg)  
[Market Cap 24-Hour Chart Data](/topic/$mltx/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$9.60%  
**1 Month**: $XXXXXXXXXXXXX +$23%  
**6 Months**: $XXXXXXXXXXXXX +$18%  
**1 Year**: $XXXXXXXXXXXXX +$21%  
**1-Year High**: $XXXXXXXXXXXXX on 2024-12-17  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about MoonLake Immunotherapeutics Class A Ordinary Shares in the last XX hours

[DAOstack (GEN)](/topic/$gen)
[Merck & Co., Inc. (MRK)](/topic/$mrk)
[SuperRare (RARE)](/topic/$rare)
[Alnylam Pharmaceuticals, Inc. (ALNY)](/topic/$alny)
[Qilian International Holding Group Ltd. Class A Ordinary Shares (BGM)](/topic/$bgm)
[Constellation Energy Corp (CEG)](/topic/$ceg)
[Expedia Group Inc (EXPE)](/topic/$expe)
[Eli Lilly and Company (LLY)](/topic/$lly)
[Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix)

**Top topics mentioned**
In the posts about MoonLake Immunotherapeutics Class A Ordinary Shares in the last XX hours

[telo](/topic/telo), [dtc](/topic/dtc), [nvda](/topic/nvda), [mor](/topic/mor), [cort](/topic/cort), [op](/topic/op), [$lrmr](/topic/$lrmr), [mira](/topic/mira), [$vrna](/topic/$vrna), [$imcr](/topic/$imcr), [$vyne](/topic/$vyne), [sonn](/topic/sonn), [abus](/topic/abus), [ate](/topic/ate), [stocks healthcare](/topic/stocks-healthcare), [$vrnt](/topic/$vrnt), [$xpof](/topic/$xpof), [$gen](/topic/$gen), [$1b](/topic/$1b), [mbx](/topic/mbx), [$cogt](/topic/$cogt), [$repl](/topic/$repl), [$lsta](/topic/$lsta), [$pcsa](/topic/$pcsa), [$binv](/topic/$binv), [octo](/topic/octo), [$ifrx](/topic/$ifrx), [pep](/topic/pep), [kyrgyzstani som](/topic/kyrgyzstani-som), [$argx](/topic/$argx), [$hnsa](/topic/$hnsa), [$mor](/topic/$mor), [$mrk](/topic/$mrk), [$rare](/topic/$rare), [$goos](/topic/$goos), [$hlf](/topic/$hlf), [$alny](/topic/$alny), [pltr](/topic/pltr), [amzn](/topic/amzn), [market cap](/topic/market-cap), [$upb](/topic/$upb), [$vrdn](/topic/$vrdn), [$mreo](/topic/$mreo), [$bgm](/topic/$bgm), [soc](/topic/soc), [$mnpr](/topic/$mnpr), [$drug](/topic/$drug), [$anab](/topic/$anab), [ske](/topic/ske), [$ceg](/topic/$ceg), [$expe](/topic/$expe), [rblx](/topic/rblx), [jnj](/topic/jnj), [nic](/topic/nic), [bmnr](/topic/bmnr), [$rapp](/topic/$rapp), [$entx](/topic/$entx), [vera](/topic/vera), [bq](/topic/bq), [sqm](/topic/sqm), [stocks](/topic/stocks), [$olma](/topic/$olma), [$lly](/topic/$lly), [nio](/topic/nio), [coins ai](/topic/coins-ai), [iren](/topic/iren), [$abus](/topic/$abus), [$caba](/topic/$caba), [$capr](/topic/$capr), [$abvx](/topic/$abvx), [$nbix](/topic/$nbix), [$abeo](/topic/$abeo), [$dmac](/topic/$dmac), [$cytk](/topic/$cytk), [$amlx](/topic/$amlx), [$prax](/topic/$prax), [sei](/topic/sei), [$hcm](/topic/$hcm), [$mdgl](/topic/$mdgl), [$iron](/topic/$iron), [$mlys](/topic/$mlys), [bla](/topic/bla), [$nu](/topic/$nu), [$phvs](/topic/$phvs), [stacking](/topic/stacking), [$onc](/topic/$onc), [coins stablecoin](/topic/coins-stablecoin), [$7240t](/topic/$7240t), [norwegian krone](/topic/norwegian-krone), [$prme](/topic/$prme), [$btbt](/topic/$btbt), [stealth](/topic/stealth), [$mnprthese](/topic/$mnprthese), [clay](/topic/clay), [din](/topic/din), [$crnt](/topic/$crnt), [$cgbsw](/topic/$cgbsw), [$gree](/topic/$gree), [$gipr](/topic/$gipr), [$npac](/topic/$npac)

### Top Social Posts [#](/topic/$mltx/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"I made $76k today buying stocks on @Yzq_hpp775 's advice.🍀🎈 And it worked. Awesome $DHAI $GCTK $APLM $DTC $TELO $CYCC $BZAI $STEM $LMFA $CELU $UAVS $OPEN $CARV $CIF $TLSI $MLTX $RBBN $BASE $FSLY $AWK $LFCR $YJ $FLNC $AAPG $KVAC"  
[@Sara3979961022](/creator/x/Sara3979961022) on [X](/post/tweet/1947100957378277498) 2025-07-21 01:06:58 UTC X followers, X engagements


"Let's see how many of the XX biopharma-focused hedge funds hold these tickers (5 is 🔥). $MLTX 7/34 🔥 $LRMR 4/34 $IFRX 1/34 Access our FREE hedge fund screener & search your fav tickers 👇"  
[@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036722971451839) 2025-07-20 20:51:43 UTC 25.6K followers, XXX engagements


"Each quarter we identify major catalyst events 🥳 Likely to move the stock +/- by XX% 📈 📉 $MLTX Sonelokimab $LRMR Nomlabofusp (CTI-1601) $IFRX INF904 Access our FREE Big Mover Report 👇"  
[@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036720882713048) 2025-07-20 20:51:43 UTC 25.6K followers, XXX engagements


"Biotech Stock Catalyst Watchlist 🚀 🎯 Ph2 & Ph3 readouts in Q3 2025. $NAMS Phase 2a $CRDF Phase X $IXHL Phase X $ENTX Phase X $MLTX Phase X $LRMR Phase X $KAPA Phase X $RAPP Phase 2a $PMVP Phase X $ATAI Phase 2b $ARCT Phase X $CLNN Phase X $AMLX Phase X $PRAX Phase 2b $ANAB Phase X $BINV Phase 2a $VYNE Phase 2b $PCSA Phase X $LSTA Phase 2a $BINV Phase 2a $LLY Phase X $ATAI Phase 2b $GRI Phase 2a $FDMT Phase X $HRMY Phase X $IONS Phase X $ENTA Phase X $KALA Phase 2b $LTRN Phase X $INBX Phase X $BTAI Phase X $PRAX Phase X $ATYR Phase X $FBIO Phase X $UPB Phase X $INMB Phase X $IFRX Phase 2a"  
[@BiopharmIQ](/creator/x/BiopharmIQ) on [X](/post/tweet/1947036716457754997) 2025-07-20 20:51:42 UTC 25.6K followers, 17.8K engagements